bioRxivCell Biology
CRISPRi Gene Modulation and All-Optical Electrophysiology in Post-Differentiated Human iPSC-Cardiomyocytes
Abstract
Uncovering gene-phenotype relationships can be enabled by precise gene modulation in human induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs) and follow up phenotyping using scalable all- optical electrophysiology platforms. Such efforts towards human functional genomics can be aided by recent CRISPR-derived technologies for reversible gene inhibition or activation (CRISPRi/a). We set out to characterize the performance of CRISPRi in post-differentiated iPSC-CMs, targeting key cardiac ion channel genes, KCNH2, KCNJ2, and GJA1, and providing a multiparametric quantification of the effects on cardiac repolarization, stability of the resting membrane potential and conduction properties using all- optical tools. More potent CRISPRi effectors, e.g. Zim3, and optimized viral delivery led to improved performance on par with the use of CRISPRi iPSC lines. Confirmed mild yet specific phenotype changes when CRISPRi is deployed in non-dividing differentiated heart cells is an important step towards more holistic pre-clinical cardiotoxicity testing and for future therapeutic use in vivo.
- organism: human
- assay: electrophysiology
- research focus: drug response / drug discovery
- research focus: cell type annotation
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: wet-lab / biochemical assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Paradoxical effects of Zim3, a CRISPRi effector, on human iPSC-cardiomyocyte electrophysiology
Julie Han, Yuli W. Heinson, … Emilia G. Entcheva·PNAS NexusPeer-reviewed·Jan 20, 2024
- Ion channel expression and electrophysiology of singular human (primary and induced pluripotent stem cell derived) cardiomyocytes
C. Schmid, N. Abi-Gerges, … G. Rast·CellsPeer-reviewed·Nov 30, 2021
- Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical Study
S. Miyagawa, T. Kawamura, … Y. Sawa·bioRxiv·Apr 7, 2021
- Derivation of human post-mitotic cardiomyocytes from tetraploid iPSCs
Ittetsu Nakajima, Mitsuyoshi Shimane, … Yuichiro Miyaoka·Communications BiologyPeer-reviewed·Aug 17, 2026
- Human iPSC-derived Committed Cardiac Progenitors Generate Cardiac Tissue Grafts in a Swine Ischemic Cardiomyopathy Model without Triggering Ventricular Arrhythmias
A. N. Raval, E. G. Schmuck, … T. J. Kamp·bioRxiv·Feb 14, 2024
- Syncytium cell growth increases IK1 contribution in human iPS-cardiomyocytes
W. Li, E. Entcheva·bioRxiv·Dec 3, 2019